Sex and outcomes after alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy

Sherif F. Nagueh

doi:10.1136/heartjnl-2022-321251

Sex and outcomes after alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy

Research output: Contribution to journal › Review article › peer-review

Abstract

Hypertrophic obstructive cardiomyopathy (HOCM) is currently treated with septal reduction therapy in severely symptomatic patients who are not responsive to medical treatment. Since its introduction by Dr Ulrich Sigwart in 1995, alcohol septal ablation (ASA) has been increasingly performed across the globe. In fact, after discussion of risks, benefits and alternatives, many patients elect to undergo ASA.

Original language	English (US)
Pages (from-to)	1588-1589
Number of pages	2
Journal	Heart
Volume	108
Issue number	20
DOIs	https://doi.org/10.1136/heartjnl-2022-321251
State	Published - Oct 1 2022

Keywords

Cardiomyopathy, Hypertrophic

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1136/heartjnl-2022-321251

Cite this

@article{ba6a3c886db64771abc2a431ea127d66,

title = "Sex and outcomes after alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy",

abstract = "Hypertrophic obstructive cardiomyopathy (HOCM) is currently treated with septal reduction therapy in severely symptomatic patients who are not responsive to medical treatment. Since its introduction by Dr Ulrich Sigwart in 1995, alcohol septal ablation (ASA) has been increasingly performed across the globe. In fact, after discussion of risks, benefits and alternatives, many patients elect to undergo ASA. ",

keywords = "Cardiomyopathy, Hypertrophic",

author = "Nagueh, {Sherif F.}",

note = "Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2022",

month = oct,

day = "1",

doi = "10.1136/heartjnl-2022-321251",

language = "English (US)",

volume = "108",

pages = "1588--1589",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "20",

}

TY - JOUR

T1 - Sex and outcomes after alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy

AU - Nagueh, Sherif F.

N1 - Publisher Copyright: © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2022/10/1

Y1 - 2022/10/1

N2 - Hypertrophic obstructive cardiomyopathy (HOCM) is currently treated with septal reduction therapy in severely symptomatic patients who are not responsive to medical treatment. Since its introduction by Dr Ulrich Sigwart in 1995, alcohol septal ablation (ASA) has been increasingly performed across the globe. In fact, after discussion of risks, benefits and alternatives, many patients elect to undergo ASA.

AB - Hypertrophic obstructive cardiomyopathy (HOCM) is currently treated with septal reduction therapy in severely symptomatic patients who are not responsive to medical treatment. Since its introduction by Dr Ulrich Sigwart in 1995, alcohol septal ablation (ASA) has been increasingly performed across the globe. In fact, after discussion of risks, benefits and alternatives, many patients elect to undergo ASA.

KW - Cardiomyopathy, Hypertrophic

UR - http://www.scopus.com/inward/record.url?scp=85132369742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132369742&partnerID=8YFLogxK

U2 - 10.1136/heartjnl-2022-321251

DO - 10.1136/heartjnl-2022-321251

M3 - Review article

C2 - 35697497

AN - SCOPUS:85132369742

SN - 1355-6037

VL - 108

SP - 1588

EP - 1589

JO - Heart

JF - Heart

IS - 20

ER -

Sex and outcomes after alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this